$NBIO A third payment of USD $2,500,000 will be re
Saturday, May 10, 2025 1:30:56 PM
Post# of 12189
Post# of 12189
(Total Views: 146)
Posted On: 02/23/2022 9:36:02 AM
$NBIO
Quote:
A third payment of USD $2,500,000 will be received by Nascent upon approval from the FDA to conduct a Phase 2 clinical trial of Pritumumab.
(0)
(0)Scroll down for more posts ▼